Vutrisiran

vutrisiran · Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vutrisiran, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran